Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

AI in Pharmacovigilance: Key Takeaways from Boehringer Ingelheim’s Recent Rollout
In conversation with Pharmaceutical Outsourcing, Claudia Lehman, Head of Global Pharmacovigilance Operations at Boehringer Ingelheim and Lucinda Smith, ArisGlobal’s Chief Safety Product Officer, reflect on some of the lessons learned from Boehringer’s deployment of AI to date in targeted use cases, starting with adverse event case intake and processing. read more
Executive Q&A - A Strategic Acquisition: Insights and Ideas
An interview with Brian Morrissey, General Manager of Gaelic Laboratories, which has acquired Athlone Laboratories in a strategic deal that typifies the current pharma M&A landscape and puts all of Ireland’s Beta-Lactam manufacturing capacity under one ownership umbrella. read more
An Interview With Andreas Eschbach
How has AI acceptance evolved in the pharmaceutical sector, and what strategies have been most effective in overcoming resistance to AI adoption? read more
Why DSCSA Compliance in 2026 Hinges on Execution, Not Implementation
After a decade of ramp-up, the era of DSCSA enforcement is no longer theoretical — it’s here. But as we move deeper into this phase of full compliance, the real story unfolds not just in establishing data feeds, but in the operational cracks that persist behind the scenes. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Avid Bioservices Appoints Chief Commercial Officer
Tuesday, May 12, 2026
Avid Bioservices announced the appointment of Kerri McCullough Wood as Chief Commercial Officer. read more
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Tuesday, May 12, 2026
Ardena announced the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as Chief Commercial Officer. These additions further ... read more
GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions
Tuesday, May 12, 2026
GI Partners, a private investment firm, announced it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) ... read more
Hovione Announces Leadership Transition and Interim Co-CEO Structure
Tuesday, May 12, 2026
Hovione announced that Dr. Jean Luc Herbeaux has decided to step down from his role as Chief Executive Officer for personal reasons, effective as of ... read more
Parexel Acquires Vitrana to Expand AI-Enabled Patient Safety and Pharmacovigilance Technology
Thursday, April 30, 2026
Parexel announced the acquisition of Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance (PV) technology platform that supports patient... read more